Enter to open, tab to navigate, enter to select
Retrophin, Inc. acquisition of equity interests of Manchester Pharmaceuticals LLC
| March 26, 2014 • Private Acquisition Agreements • $56.8 million (subject to additional earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.